好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neurological Manifestations of PTEN Hamartoma Syndrome: A Review Through Cases
Neuro-oncology
P4 - Poster Session 4 (5:00 PM-6:00 PM)
6-006
To present two case reports of atypical neuro-oncologic presentations which were found to be associated with mutations in PTEN

Mutations in the gene PTEN (phosphate and tensin homologue) are associated with a variety of neurologic and non-neurologic manifestations. The full spectrum of neurologic diseases associated with PTEN mutations has not yet been characterized.

Case report.

A 19-year-old male with past medical history of Crohn’s disease with a preexisting diagnosis of the PTEN hamartoma syndrome presented to the neurology clinic after incidental identification of multiple T2 hyperintense contrast enhancing lesions in the lumbar spine on an abdominal MRI for his Crohn’s disease. He had no symptoms of myelopathy and a normal neurologic exam. Spine MRI demonstrated thoracic and lumbar paraspinal masses and lumbar nerve sheath masses. Biopsy of one of the paraspinal lesions showed pathology consistent with ganglioneuroma. This is the first case of which we are aware with paraspinal and nerve sheath ganglioneuromas in a patient with a PTEN hamartoma syndrome.

A 40-year-old female presented with new onset bilateral frontotemporal headaches. Neurologic exam was normal. Brain MRI showed a 7 x 8 cm area of T2 hyperintensity without gadolinium contrast enhancement in the right frontal lobe. The patient underwent subtotal resection of the mass. Pathology was consistent with a cerebral malformation with mild glial hypercellularity. Genetic analysis showed a point mutation in PTEN (c.517C>T, p.R173C). Spine MRI and follow up brain MRI did not show any additional tumor or disease recurrence.

Mutations in PTEN can present with space occupying lesions within the central nervous system, and the full spectrum of this disease presentation has not been well defined. We have described two atypical presentations of PTEN associated lesions which further expands our understanding of the range of effects of mutations in this gene.

Authors/Disclosures
Andrew M. Williams, MD (Mayo Clinic School of Graduate Medical 好色先生)
PRESENTER
Dr. Williams has nothing to disclose.
Derek Johnson, MD (Mayo Clinic) Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix.
Ian Parney, MD, PhD The institution of Dr. Parney has received research support from National Cancer Institute.
Ugur Sener, MD Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.